Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease

Clinical trial NCT07281456 · RECRUITING

Trial details

NCT number: NCT07281456
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sjogren's Syndrome

Start date: 2025-12-18
Primary completion: 2030-12-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.